Falony Gwen, Vandeputte Doris, Caenepeel Clara, Vieira-Silva Sara, Daryoush Tanine, Vermeire Séverine, Raes Jeroen
a Laboratory of Molecular Bacteriology, Department of Microbiology and Immunology , Rega Institute, KU Leuven , Leuven , Belgium.
b Center for Microbiology , VIB , Leuven , Belgium.
Acta Clin Belg. 2019 Apr;74(2):53-64. doi: 10.1080/17843286.2019.1583782. Epub 2019 Feb 27.
The prognostic, diagnostic, and therapeutic potential of the human gut microbiota is widely recognised. However, translation of microbiome findings to clinical practice is challenging. Here, we discuss current knowledge and applications in the field.
We revisit some recent advances in the field of faecal microbiome analyses with a focus on covariate analyses and ecological interpretation.
Population-level characterization of gut microbiota variation among healthy volunteers has allowed identifying microbiome covariates required for clinical studies. Currently, microbiome research is moving from relative to quantitative approaches that will shed a new light on microbiota-host interactions in health and disease.
Covariate characterization and technical advances increase reproducibility of microbiome research. Targeted in vitro/in vivo intervention studies will accelerate clinical implementation of microbiota findings.
人类肠道微生物群在预后、诊断和治疗方面的潜力已得到广泛认可。然而,将微生物组研究结果转化为临床实践具有挑战性。在此,我们讨论该领域的当前知识和应用。
我们回顾粪便微生物组分析领域的一些最新进展,重点是协变量分析和生态学解释。
对健康志愿者肠道微生物群变异的人群水平特征分析,有助于确定临床研究所需的微生物组协变量。目前,微生物组研究正从相对方法转向定量方法,这将为健康和疾病中的微生物群与宿主相互作用带来新的认识。
协变量特征分析和技术进步提高了微生物组研究的可重复性。有针对性的体外/体内干预研究将加速微生物群研究结果的临床应用。